Green Lifescience Co., Ltd. (KOSDAQ:114450)

Market Cap	58.58B +88.1%
Revenue (ttm)	40.34B +62.3%
Net Income	110.13M -92.9%
EPS	5.74 -92.9%
Shares Out	19.53M
PE Ratio	531.89
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	8,885,994
Average Volume	2,395,897
Open	2,945.00
Previous Close	2,860.00
Day's Range	2,925.00 - 3,330.00
52-Week Range	1,652.00 - 4,640.00
Beta	0.79
RSI	52.16
Earnings Date	Mar 27, 2026

About Green Lifescience

Green Lifescience Co., Ltd. engages in development, production, and sale of agrochemical raw materials and pharmaceutical intermediates in South Korea and internationally. The company offers raw materials for pharmaceuticals and pesticides; and primary intermediates to the pharmaceutical and agrochemical markets. It also develops EDP-CL, a piperacillin antibiotic intermediate; N,N-disuccinimidyl carbonate used for the synthesis of HIV treatment; Amoxapine, an antidepressant raw drug, and AM19, an antibiotic intermediate, as well as 1,1'-carbony...

• Industry: Medicinal Chemicals and Botanical Products
• Founded: 2005
• Employees: 70
• Stock Exchange: KOSDAQ
• Ticker Symbol: 114450

Financial Performance

In 2025, Green Lifescience's revenue was 40.34 billion, an increase of 62.26% compared to the previous year's 24.86 billion. Earnings were 110.13 million, a decrease of -92.95%.